Related Experiment Videos
High-dose or dose-intensive chemotherapy for non-small cell carcinoma of the lung
1Division of Hematology/Oncology, Mount Sinai Hospital, Toronto, Canada.
Seminars in Oncology
|February 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Biomarker testing and time to treatment decision in patients with advanced nonsmall-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2015
Randomized phase II trial of pemetrexed/cisplatin with or without CBP501 in patients with advanced malignant pleural mesothelioma.
Lung cancer (Amsterdam, Netherlands)·2014
Cotrimoxazole-resistant Escherichia coli bacteremia in neutropenic patients at a regional oncology hospital.
The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2012
Reduction in clinical response to empiric antimicrobial therapy of febrile granulocytopenic patients receiving TMP/SMX infection prophylaxis.
The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2012
Rhabdomyolysis resulting from the interaction of rosuvastatin and abiraterone: A case study.
Seminars in oncology·2026
NK3 subsets are linked to NK cell exhaustion and immunotherapy responsiveness in tumor.
Seminars in oncology·2026
Dual alexithymia: A relational framework for clinical communication in oncology.
Seminars in oncology·2026
SPIB as a context-specific regulator in cancer: from molecular mechanisms to clinical implications.
Seminars in oncology·2026
The role of fumarate and itaconate in tumor microenvironment.
Seminars in oncology·2026
Management of ectopic Cushing syndrome in medullary thyroid carcinoma: from case reports to systematic literature review.
Frontiers in endocrinology·2026
Catatonic Features That May Be Mistaken for Worsening Autism Show Treatment-Associated Improvement: Implications for Later Regression.
medRxiv : the preprint server for health sciences·2026
Integrative pipeline to profile and target endocrine therapy-insensitive cell populations in ER+ breast cancer.
bioRxiv : the preprint server for biology·2026